Physician profile
Fernando Mora
NPI 1386817427
$6,688.31
in general payments reported to CMS, 2019-2025
14 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $1,923 · 2021: $13.68 · 2022: $1,617 · 2023: $68.23 · 2024: $2,037 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,272 · Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,271.74 |
| Food and Beverage | $1,166.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,238.09 | 2019-2020 | |
| Spinal Simplicity, LLC | $1,742.71 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Mml US, INC. | $1,445.60 | 2022 | |
| Nevro Corp. | $481.11 | 2019-2024 | Senza |
| Stryker Corporation | $267.56 | 2024 | Optablate, Mako |
| Astrazeneca Pharmaceuticals Lp | $182.41 | 2019 | |
| Bone Support INC. | $130.73 | 2025 | Ceramentbone Void Filler, Cerament G |
| Abbott Laboratories | $49.52 | 2019 | |
| Bioventus LLC | $45.19 | 2025 | Xcell |
| Southern Edge Orthopaedics, INC. | $35.83 | 2022 | |
| Gilead Sciences, INC. | $21.25 | 2024 | |
| Relievant Medsystems, INC. | $20.81 | 2022 | |
| Globus Medical, INC. | $13.82 | 2025 | Senza |
| Depuy Synthes Sales INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Mora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.